Preliminary experiments show conolidine may inhibit precise ion channels, reducing neuronal excitability and restricting ache alerts. This mechanism is particularly appropriate in neuropathic pain, in which irregular signaling causes persistent pain. Moreover, conolidine seems to impact G protein-coupled receptor (GPCR) pathways integral to pain pe